Published in Nat Cell Biol on October 18, 2009
Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell (2011) 6.21
Collective cell guidance by cooperative intercellular forces. Nat Mater (2011) 4.64
Tumors as organs: complex tissues that interface with the entire organism. Dev Cell (2010) 3.98
Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia (2010) 3.93
Chemotaxis in cancer. Nat Rev Cancer (2011) 3.68
To differentiate or not--routes towards metastasis. Nat Rev Cancer (2012) 3.59
Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells. Immunity (2013) 3.51
The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer (2011) 3.42
Intravital imaging. Cell (2011) 3.18
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech (2011) 2.97
Collective chemotaxis requires contact-dependent cell polarity. Dev Cell (2010) 2.95
Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer (2010) 2.94
Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin β1/FAK signaling. Cancer Cell (2015) 2.94
Classifying collective cancer cell invasion. Nat Cell Biol (2012) 2.83
Tumor metastasis: moving new biological insights into the clinic. Nat Med (2013) 2.71
The roles of TGFβ in the tumour microenvironment. Nat Rev Cancer (2013) 2.35
Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc Natl Acad Sci U S A (2012) 2.29
Epithelial stem cells, wound healing and cancer. Nat Rev Cancer (2012) 2.23
Crossing the endothelial barrier during metastasis. Nat Rev Cancer (2013) 2.00
Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer. J Cell Sci (2011) 2.00
Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Res (2012) 2.00
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse. J Clin Invest (2011) 1.88
Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell (2010) 1.86
Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes. J Pathol (2013) 1.86
CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci (2009) 1.84
MicroRNA-204/211 alters epithelial physiology. FASEB J (2010) 1.83
Plithotaxis and emergent dynamics in collective cellular migration. Trends Cell Biol (2011) 1.79
Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol (2010) 1.77
Myosin-IXA regulates collective epithelial cell migration by targeting RhoGAP activity to cell-cell junctions. Curr Biol (2012) 1.70
Initial steps of metastasis: cell invasion and endothelial transmigration. Mutat Res (2011) 1.67
KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene (2010) 1.65
Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion. Breast Cancer Res (2013) 1.64
Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis. Mol Biol Cell (2011) 1.54
Receptor tyrosine kinase coactivation networks in cancer. Cancer Res (2010) 1.46
Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients. Breast Cancer Res (2012) 1.43
Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol Cancer Res (2011) 1.42
Noncanonical TGF-β signaling during mammary tumorigenesis. J Mammary Gland Biol Neoplasia (2011) 1.38
Intravital microscopy: new insights into metastasis of tumors. J Cell Sci (2011) 1.36
The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression. Cell Adh Migr (2012) 1.34
Imaging hallmarks of cancer in living mice. Nat Rev Cancer (2014) 1.32
Metastatic colonization by circulating tumour cells. Nature (2016) 1.31
Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1. Mol Cancer (2011) 1.30
TGF-β signaling in breast cancer cell invasion and bone metastasis. J Mammary Gland Biol Neoplasia (2011) 1.28
Loss of E-cadherin activates EGFR-MEK/ERK signaling, which promotes invasion via the ZEB1/MMP2 axis in non-small cell lung cancer. Oncotarget (2013) 1.27
2D protrusion but not motility predicts growth factor-induced cancer cell migration in 3D collagen. J Cell Biol (2012) 1.26
TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer. Nat Commun (2012) 1.23
Mena invasive (Mena(INV)) and Mena11a isoforms play distinct roles in breast cancer cell cohesion and association with TMEM. Clin Exp Metastasis (2011) 1.23
Dynamics of TGF-β signaling reveal adaptive and pulsatile behaviors reflected in the nuclear localization of transcription factor Smad4. Proc Natl Acad Sci U S A (2012) 1.23
Intravital multiphoton imaging reveals multicellular streaming as a crucial component of in vivo cell migration in human breast tumors. Intravital (2013) 1.22
Multiparametric classification links tumor microenvironments with tumor cell phenotype. PLoS Biol (2014) 1.22
Hemocyte-secreted type IV collagen enhances BMP signaling to guide renal tubule morphogenesis in Drosophila. Dev Cell (2010) 1.20
NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer. PLoS One (2011) 1.19
Intravital imaging illuminates transforming growth factor beta signaling switches during metastasis. Cancer Res (2010) 1.18
The relevance of the TGF-β Paradox to EMT-MET programs. Cancer Lett (2013) 1.18
Targeting TGF-β signaling in cancer. Expert Opin Ther Targets (2013) 1.16
New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med (2015) 1.12
Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Front Biosci (Landmark Ed) (2011) 1.12
Traversing the basement membrane in vivo: a diversity of strategies. J Cell Biol (2014) 1.11
Cell invasion through basement membrane: the anchor cell breaches the barrier. Curr Opin Cell Biol (2011) 1.11
Normal morphogenesis of epithelial tissues and progression of epithelial tumors. Wiley Interdiscip Rev Syst Biol Med (2011) 1.10
Diverse matrix metalloproteinase functions regulate cancer amoeboid migration. Nat Commun (2014) 1.08
Real-time motion analysis reveals cell directionality as an indicator of breast cancer progression. PLoS One (2013) 1.08
Integrins and metastasis. Cell Adh Migr (2013) 1.08
TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Oncogene (2015) 1.07
Cellular mechanisms regulating epithelial morphogenesis and cancer invasion. Curr Opin Cell Biol (2010) 1.07
Myosin II isoform switching mediates invasiveness after TGF-β-induced epithelial-mesenchymal transition. Proc Natl Acad Sci U S A (2011) 1.07
EphA2 cleavage by MT1-MMP triggers single cancer cell invasion via homotypic cell repulsion. J Cell Biol (2013) 1.06
Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. Breast Cancer Res (2012) 1.05
Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells. Oncogenesis (2013) 1.05
Cell adhesion and its endocytic regulation in cell migration during neural development and cancer metastasis. Int J Mol Sci (2012) 1.04
Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut. Nat Commun (2014) 1.04
Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery. BMC Cancer (2012) 1.02
Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging. Cell Adh Migr (2011) 1.00
DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin. Mol Biol Cell (2011) 1.00
Caught in the act: revealing the metastatic process by live imaging. Dis Model Mech (2013) 0.99
Transient SNAIL1 expression is necessary for metastatic competence in breast cancer. Cancer Res (2014) 0.98
c-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic Cascade. Genes Cancer (2013) 0.98
Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer. Front Oncol (2013) 0.98
Diverse roles for the paxillin family of proteins in cancer. Genes Cancer (2012) 0.98
In vivo dual substrate bioluminescent imaging. J Vis Exp (2011) 0.97
SMRT analysis of MTOC and nuclear positioning reveals the role of EB1 and LIC1 in single-cell polarization. J Cell Sci (2011) 0.96
Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization. Cell Rep (2015) 0.96
Measurement and modeling of signaling at the single-cell level. Biochemistry (2012) 0.96
Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling. Clin Cancer Res (2011) 0.96
Rho GTPases in collective cell migration. Small GTPases (2014) 0.96
FER kinase promotes breast cancer metastasis by regulating α6- and β1-integrin-dependent cell adhesion and anoikis resistance. Oncogene (2013) 0.95
Cell migration. Compr Physiol (2012) 0.94
Emerging roles of the tumor-associated stroma in promoting tumor metastasis. Cell Adh Migr (2012) 0.94
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance. Cancer Metastasis Rev (2014) 0.94
Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression. Int J Cancer (2010) 0.93
Retracted The transcription factor sterile alpha motif (SAM) pointed domain-containing ETS transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells. J Biol Chem (2013) 0.93
Mesenchymal mode of migration participates in pulmonary metastasis of mouse osteosarcoma LM8. Clin Exp Metastasis (2010) 0.92
Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells. BMC Cancer (2012) 0.92
c-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer. Carcinogenesis (2012) 0.92
Cell cycle-dependent Rho GTPase activity dynamically regulates cancer cell motility and invasion in vivo. PLoS One (2013) 0.92
The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC. PLoS One (2013) 0.92
ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion. Oncotarget (2016) 0.92
Membrane-type-3 matrix metalloproteinase (MT3-MMP) functions as a matrix composition-dependent effector of melanoma cell invasion. PLoS One (2011) 0.91
Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol (2004) 36.25
Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer (2002) 17.49
TGF-beta and epithelial-to-mesenchymal transitions. Oncogene (2005) 10.02
Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J (1998) 10.01
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer (2003) 8.35
TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell (2008) 7.60
EGFR and cancer prognosis. Eur J Cancer (2001) 7.52
Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature (2007) 7.05
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res (2007) 6.60
Intravital imaging of cell movement in tumours. Nat Rev Cancer (2003) 6.35
New insights into TGF-beta-Smad signalling. Trends Biochem Sci (2004) 6.13
TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev (2002) 4.66
Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res (2005) 4.33
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci U S A (2005) 4.20
Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev (2005) 4.05
Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res (2004) 4.04
Illuminating the metastatic process. Nat Rev Cancer (2007) 3.80
Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol (2004) 3.78
ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol (2006) 3.55
Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev (2006) 3.14
Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo. Cells Tissues Organs (2007) 3.12
A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res (2000) 3.03
Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci U S A (1990) 2.72
A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell (2008) 2.65
Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res (2003) 2.30
Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res (2000) 2.23
Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res (2003) 2.20
Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res (2006) 2.17
Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol Cell Biol (1999) 2.08
Simultaneous imaging of GFP, CFP and collagen in tumors in vivo using multiphoton microscopy. BMC Biotechnol (2005) 1.93
Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads. Mol Cell Biol (2005) 1.84
Analysis of Smad nucleocytoplasmic shuttling in living cells. J Cell Sci (2004) 1.70
Transforming growth factor-beta signaling in cancer invasion and metastasis. Int J Cancer (2007) 1.70
The biological role of HGF-MET axis in tumor growth and development of metastasis. Front Biosci (2008) 1.32
Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior. J Biol Chem (2004) 1.12
Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer. Breast Cancer Res (2000) 1.07
The epidermal growth factor receptor in breast cancer. J Mammary Gland Biol Neoplasia (1997) 1.03
Mutations of the BRAF gene in human cancer. Nature (2002) 65.42
SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol (2002) 8.89
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol (2007) 7.20
TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol (2007) 6.34
New insights into TGF-beta-Smad signalling. Trends Biochem Sci (2004) 6.13
Rac activation and inactivation control plasticity of tumor cell movement. Cell (2008) 6.01
Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res (2005) 4.33
Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev (2005) 4.05
Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res (2004) 4.04
Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A. Cancer Cell (2011) 4.02
Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell (2007) 3.89
Spreading of RNA targeting and DNA methylation in RNA silencing requires transcription of the target gene and a putative RNA-dependent RNA polymerase. Plant Cell (2002) 3.73
ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr Biol (2006) 3.55
Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell (2009) 3.51
ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell (2003) 3.28
An RNA-dependent RNA polymerase prevents meristem invasion by potato virus X and is required for the activity but not the production of a systemic silencing signal. Plant Physiol (2005) 3.14
Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol Cell (2002) 3.10
Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol (2009) 3.09
TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A (2004) 3.04
Classifying collective cancer cell invasion. Nat Cell Biol (2012) 2.83
The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis (2008) 2.82
ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell (2011) 2.77
Interventions for supporting informal caregivers of patients in the terminal phase of a disease. Cochrane Database Syst Rev (2011) 2.76
Dementia in the acute hospital: prospective cohort study of prevalence and mortality. Br J Psychiatry (2009) 2.75
A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell (2008) 2.65
Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat Cell Biol (2010) 2.58
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol (2013) 2.58
How the Smads regulate transcription. Int J Biochem Cell Biol (2007) 2.46
Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Mol Cell Biol (2005) 2.41
Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol (2004) 2.28
Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol (2008) 2.27
PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nat Cell Biol (2008) 2.27
Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res (2006) 2.17
Controlling long-term signaling: receptor dynamics determine attenuation and refractory behavior of the TGF-β pathway. Sci Signal (2013) 2.11
Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol (2005) 2.04
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res (2013) 1.92
Enteral tube feeding for older people with advanced dementia. Cochrane Database Syst Rev (2009) 1.90
Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes. J Pathol (2013) 1.86
Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads. Mol Cell Biol (2005) 1.84
Matrix geometry determines optimal cancer cell migration strategy and modulates response to interventions. Nat Cell Biol (2013) 1.84
Expansins and cell growth. Curr Opin Plant Biol (2003) 1.83
Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res (2004) 1.81
LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells. J Cell Biol (2010) 1.79
Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest. Oncogene (2003) 1.76
Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting system. Proc Natl Acad Sci U S A (2008) 1.75
Analysis of Smad nucleocytoplasmic shuttling in living cells. J Cell Sci (2004) 1.70
Beyond TGFβ: roles of other TGFβ superfamily members in cancer. Nat Rev Cancer (2013) 1.67
Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A (2010) 1.66
Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol (2007) 1.65
Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res (2009) 1.63
SNW1 is a critical regulator of spatial BMP activity, neural plate border formation, and neural crest specification in vertebrate embryos. PLoS Biol (2011) 1.48
New dimensions in cell migration. Nat Rev Mol Cell Biol (2012) 1.46
Cancer dissemination--lessons from leukocytes. Dev Cell (2010) 1.46
Dynamics of T cell responses in HIV infection. J Immunol (2002) 1.44
Recruitment of TIF1γ to chromatin via its PHD finger-bromodomain activates its ubiquitin ligase and transcriptional repressor activities. Mol Cell (2011) 1.43
Kinesin-mediated transport of Smad2 is required for signaling in response to TGF-beta ligands. Dev Cell (2007) 1.36
A new class of small molecule inhibitor of BMP signaling. PLoS One (2013) 1.36
Melanoma invasion - current knowledge and future directions. Pigment Cell Res (2007) 1.33
Cell communication networks in cancer invasion. Curr Opin Cell Biol (2011) 1.31
Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription. EMBO J (2006) 1.30
Epithelial to mesenchymal transition in Madin-Darby canine kidney cells is accompanied by down-regulation of Smad3 expression, leading to resistance to transforming growth factor-beta-induced growth arrest. J Biol Chem (2002) 1.26
Acceptability of an advance care planning interview schedule: a focus group study. Palliat Med (2007) 1.23
Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain (2011) 1.22
Different Smad2 partners bind a common hydrophobic pocket in Smad2 via a defined proline-rich motif. EMBO J (2002) 1.20
Tumor cell migration in three dimensions. Methods Enzymol (2006) 1.18
The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration. Mol Biol Cell (2010) 1.18
Intravital imaging illuminates transforming growth factor beta signaling switches during metastasis. Cancer Res (2010) 1.18
RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation. Nat Cell Biol (2011) 1.17
Palliative assessment and advance care planning in severe dementia: an exploratory randomized controlled trial of a complex intervention. Palliat Med (2011) 1.17
Barriers to providing end-of-life care for people with dementia: a whole-system qualitative study. BMJ Support Palliat Care (2012) 1.16
Reducing emotional distress in people caring for patients receiving specialist palliative care. Randomised trial. Br J Psychiatry (2007) 1.15
TobEA: an atlas of tobacco gene expression from seed to senescence. BMC Genomics (2010) 1.14
Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. J Natl Cancer Inst (2013) 1.13
Palliative care in advanced heart failure: an international review of the perspectives of recipients and health professionals on care provision. J Card Fail (2010) 1.12
A novel Cripto-related protein reveals an essential role for EGF-CFCs in Nodal signalling in Xenopus embryos. Dev Biol (2006) 1.12
Stoichiometry of active smad-transcription factor complexes on DNA. J Biol Chem (2002) 1.12
Laxatives or methylnaltrexone for the management of constipation in palliative care patients. Cochrane Database Syst Rev (2011) 1.12
Transforming growth factor β inhibits bone morphogenetic protein-induced transcription through novel phosphorylated Smad1/5-Smad3 complexes. Mol Cell Biol (2012) 1.11
Two highly related regulatory subunits of PP2A exert opposite effects on TGF-beta/Activin/Nodal signalling. Development (2008) 1.11
Prospective, randomized, double-blind trial investigating the effect of doxycycline on matrix metalloproteinase expression within atherosclerotic carotid plaques. Stroke (2002) 1.09
Compromised virus-induced gene silencing in RDR6-deficient plants. Plant Physiol (2009) 1.07
Allergen-specific CD8(+) T cells and atopic disease. J Clin Invest (2002) 1.07
Recognition of phosphorylated-Smad2-containing complexes by a novel Smad interaction motif. Mol Cell Biol (2004) 1.06
Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells. Biochem J (2004) 1.05
In vivo fluorescence resonance energy transfer imaging reveals differential activation of Rho-family GTPases in glioblastoma cell invasion. J Cell Sci (2012) 1.05
Spatial regulation of BMP activity. FEBS Lett (2012) 1.05
The influence of early feeding practices on fruit and vegetable intake among preschool children in 4 European birth cohorts. Am J Clin Nutr (2013) 1.04
Drug therapy for delirium in terminally ill adult patients. Cochrane Database Syst Rev (2012) 1.03
Loss of Rb overrides the requirement for ERK activity for cell proliferation. J Cell Sci (2002) 1.03
The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain (2005) 1.02
Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka. PLoS One (2008) 1.02
Imaging tumor cell movement in vivo. Curr Protoc Cell Biol (2007) 1.02
Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth factor-beta responses. J Biol Chem (2009) 1.02
Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13). Psychooncology (2012) 1.01